Abnormal aggregation of tau protein is highly correlated with the pathogenesis of Alzheimer’s disease (AD), therefore, with the ability in mitigating aggregation and cytotoxicity of tau [403] anthraquinones possesses high potential in modulating AD. The gene discussed is MAPT; the disease is Alzheimer disease.